2 68% of patients were at very high risk for CKD progression 2,k Patient characteristics at baseline (N=3533) 1,2 k Patients were classified as very high risk for CKD progressing according to Kidney Disease: Improving Global Outcomes (KDIGO) risk calculators based on GFR and albuminuria categories
Serious concerns include cardiovascular effects, metabolic acidosis, psychiatric symptoms including depression and suicidal ideation, and significant teratogenic risks requiring strict pregnancy prevention measures
Risk oversight in the SkinnyRx program reflects checkout-first enrollment, clinician-controlled prescribing, and pharmacy-controlled dispensing that occurs outside the platform
These approaches include the combined use of STING agonists, Nrf2 inhibitors, lactate metabolism blockers, and mitoNIDs, which collectively alleviate immunosuppressive metabolic states, restore T cell function [89,90,91], and improve the responsiveness of MSS CRC to immune ICIs
STEP 9 didnt measure surgery rates, so the direct answer isnt in the data yet
